Bayesian Capital Management, LP Pfizer Inc Transaction History

Bayesian Capital Management, LP

$788 Million
Q4 2024

A detailed history of Bayesian Capital Management, LP transactions in Pfizer Inc stock. As of the latest transaction made, Bayesian Capital Management, LP holds 181,600 shares of PFE stock, worth $4.74 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

181,600

Previous 140,800 28.98%

Holding current value

$4.74 Million

Previous $4.07 Million 18.24%

% of portfolio

0.61%

Previous 0.49%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$24.8 - $30.19 $1.01 Million - $1.23 Million	40,800 Added 28.98%	181,600 $4.82 Million
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $2.37 Million - $2.69 Million	85,700 Added 155.54%	140,800 $4.07 Million
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $4.17 Million - $4.88 Million	-164,900 Reduced 74.95%	55,100 $1.54 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $1.16 Million - $1.33 Million	44,800 Added 25.57%	220,000 $6.11 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $1.66 Million - $2.16 Million	63,600 Added 56.99%	175,200 $5.04 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $1.65 Million - $1.92 Million	51,300 Added 85.07%	111,600 $3.7 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $1.29 Million - $1.5 Million	35,800 Added 146.12%	60,300 $2.21 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $965,055 - $1.26 Million	24,500 New	24,500 $999,000
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $856,152 - $1.02 Million	18,400 New	18,400 $965,000
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $274,500 - $340,140	-6,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $1.19 Million - $1.77 Million	-28,900 Reduced 82.81%	6,000 $354,000
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $31,400 - $40,336	-800 Reduced 2.24%	34,900 $1.5 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $2.18 Million - $2.47 Million	-60,644 Reduced 62.95%	35,700 $1.4 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $1.6 Million - $1.8 Million	47,644 Added 97.83%	96,344 $3.49 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $1.63 Million - $2.07 Million	48,700 New	48,700 $1.79 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $2.57 Million - $3.12 Million	-85,400 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $2.31 Million - $3.3 Million	85,400 New	85,400 $2.79 Million

Others Institutions Holding PFE

# of Institutions

3,359

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $146B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Account

Bayesian Capital Management, LP Pfizer Inc Transaction History